Tue, November 23, 2021

Chris Shibutani Initiated (TRDA) at Hold and Held Target at $29 on, Nov 23rd, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-29-on-nov-23rd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Chris Shibutani of Goldman Sachs, Initiated "Entrada Therapeutics, Inc." (TRDA) at Hold and Held Target at $29 on, Nov 23rd, 2021.

Chris, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30